Living donor liver transplantation for pediatric patients with inheritable metabolic disorders

American Journal of Transplantation

Volumn 5, Issue 11, 2005, Pages 2754-2763

  Morioka, Daisuke ^a,c   Kasahara, Mureo ^a   Takada, Yasutsugu ^b   Corrales, Jose Pablo Garbanzo ^b   Yoshizawa, Atsushi ^a   Sakamoto, Seisuke ^a   Taira, Kaoru ^b   Yoshitoshi, Elena Yukie ^b   Egawa, Hiroto ^a   Shimada, Hiroshi ^c   Tanaka, Koichi ^b  

^a KYOTO UNIVERSITY HOSPITAL   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Donor selection; Heterozygous carrier; Mode of inheritance

Indexed keywords

METHYLMALONIC ACID; ORNITHINE CARBAMOYLTRANSFERASE;

ADOLESCENT; ARTICLE; AUTOSOMAL RECESSIVE DISORDER; CHILD; CLINICAL ARTICLE; CRIGLER NAJJAR SYNDROME; DISORDERS OF AMINO ACID AND PROTEIN METABOLISM; ERYTHROPOIETIC PROTOPORPHYRIA; FEMALE; GLYCOGEN STORAGE DISEASE; HETEROZYGOSITY; HUMAN; LIVER GRAFT; LIVER TRANSPLANTATION; LIVING DONOR; MALE; METABOLIC DISORDER; METHYLMALONIC ACIDEMIA; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROPIONIC ACIDEMIA; QUALITY OF LIFE; SURVIVAL RATE; TYROSINEMIA; WILSON DISEASE; GENETICS; INFANT; LIVER DISEASE; LIVER RESECTION; METHODOLOGY; MORTALITY; NEWBORN; PHYSIOLOGY; PRESCHOOL CHILD; RISK FACTOR; SURVIVAL; TIME; TRANSPLANTATION; TREATMENT OUTCOME;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; HEPATECTOMY; HUMANS; INFANT; INFANT, NEWBORN; LIVER DISEASES; LIVER TRANSPLANTATION; LIVING DONORS; MALE; METABOLIC DISEASES; RISK FACTORS; SURVIVAL ANALYSIS; TIME FACTORS; TISSUE AND ORGAN HARVESTING; TREATMENT OUTCOME;

EID: 33644803431     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2005.01084.x     Document Type: Article

References (32)

1. Shneider BL. Pediatric liver transplantation in metabolic disease: clinical decision making. Pediatr Transplant 2002 6: 25 29.
2. Burdelski M. Liver transplantation in metabolic diseases: current status. Pediatr Transplant 2002 6: 361 363.
3. Asonuma K Inomata Y Kasahara M et al. Living related liver transplantation from heterozygote genetic carriers to children with Wilson's disease. Pediatr Transplant 1999 3: 201 205.
4. Morioka D Takada Y Kasahara M et al. Living donor liver transplantation for non-cirrhotic inheritable metabolic liver diseases: impact of the use of heterozygous donors. Transplantation 2005 ( in press).
5. Kasahara M Kiuchi T Uryuhara K et al. Treatment of ornithine transcarbamylase deficiency in girls by auxiliary liver transplantation: conceptual changes in living-donor program. J Pediatr Surg 1998 33: 1753 1756.
6. Yorifuji T Muroi J Uematsu A Nakahata T Egawa H Tanaka K. Living-related liver transplantation for neonatal-onset propionic acidemia. J Pediatr 2000 137: 572 574.
7. Kasahara M Takada Y Kozaki K et al. Functional portal flow competition after auxiliary partial orthotopic living donor liver transplantation in noncirrhotic metabolic liver disease. J Pediatr Surg 2004 39: 1138 1141.
8. Whitington PF Alonso EM Boyle JT et al. Liver transplantation for the treatment of urea cycle disorders. J Inherit Metab Dis 1998 21 ( Suppl 1 S112 118.
9. Russo PA Mitchell GA Tanguay RM. Tyrosinemia: a review. Pediatr Dev Pathol 2001 4: 212 221.
10. Matern D Starzl TE Arnaout W et al. Liver transplantation for glycogen storage disease types I, III and IV. Eur J Pediatr 1999 158 ( Suppl 2 S43 S48.
11. Bove KE Heubi JE Balistereri WF Setchell KDR. Bile acid synthetic defects and liver disease: a comprehensive review. Pediatr Dev Pathol 2004 7: 315 334.
12. Do KD Banner BF Katz E Szymanski IO Bonkovsky HL. Benefits of chronic plasmapheresis and intravenous heme-albumin in erythropoietic protoporphyria after orthotopic liver transplantation. Transplantation 2002 73: 469 472.
13. Morimoto T Ichiyama M Tanaka A et al. Guidelines for donor selection and an overview of the donor operation in living related liver transplantation. Transpl Int 1996 9: 208 213.
14. Fujita S Kim ID Uryuhara K et al. Hepatic grafts from live donors: donor morbidities for 470 cases of liver donation. Transpl Int 2000 13: 333 339.
15. Hauser ER Finkelstein JE Valle D Brusilow SW. Allopurinol-induced orotiduria. A test for mutaions at the ornithine carbamoyltransferase locus in women. N Eng J Med 1990 322: 1641 1645.
16. Arranz JA Riudor E Rodes M et al. Optimization of allopurinol challenge: sample purification, protein intake control and the use of orotidine response as a discriminative variable improve performance of the test for diagnosing ornithine carbamoyltransferase deficiency. Clin Chem 1999 45: 995 1001.
17. Yorifuji T Muroi J Uematsu A et al. X-inactivation pattern in the liver of a manifesting female with ornithine transcarbamylase (OTC) deficiency. Clin Genet 1998 54: 349 353.
18. Egawa H Oike F Buhler L et al. Impact of age on outcome of ABO-incompatible living donor liver transplantation. Transplantation 2004 77: 403 411.
19. Miyagawa-Hayashino A Haga H Egawa H et al. Outcome and risk factors of de novo autoimmune hepatitis in living-donor liver transplantation. Transplantation 2004 78: 128 135.
20. Do KD Banner BF Katz E Szymanski IO Bonkovski HL. Benefits of chronic plasmapheresis and intravenous heme-albumin in erythropoietic protoporphyria after orthotopic liver transplantation. Transplantation 2002 73: 469 472.
21. Dellon ES Szczepiorkowski ZM Dzik WH et al. Treatment of recurrent allograft dysfunction with intravenous hematin after liver transplantation for erythropoietic protoporphyria. Transplantation 2002 73: 911 915.
22. van't Hoff WG Dixon M Taylor J et al. Combined liver-kidney transplantation in methylmalonic academia. J Pediatr 1998 132: 1043 1044.
23. Bhattacharya N Heaton N Rela M Walter JH Lee PJ. The benefits of liver transplantation in glycogenosis type Ib. J Inherit Metab Dis 2004 27: 539 540.
24. Chou JY Matern D Mansfield BC Chen YT. Type I glycogen storage diseases: disorders of the glucose-6-phosphate complex. Curr Mol Med 2002 2: 121 143.
25. Stankovics J Crane AM Andrews E Wu CH Wu GY Ledley FD. Overexpression of human methylmalonic CoA mutase in mice after in vivo gene transfer with asialoglycoprotein/ polylysine/ DNA complexes. Hum Gene Ther 1994 5: 1095 1104.
26. Richard E Robert E Cario-Andre M et al. Hematopoietic stem cell gene therapy of murine protoporphyria by methylguanine-DNA-methyltransferase-mediated in vivo drug selection. Gene Ther 2004 11: 1638 1647.
27. Broelsch CE Emond JC Whitington PF Thistlethwaite JR Baker AL Lichtor JL. Application of reduced-size liver transplants as split grafts, auxiliary orthotopic grafts and living related segmental transplants. Ann Surg 1990 212: 368 375.
28. Kasahara M Kaihara S Oike F et al. Living-donor liver transplantation with monosegments. Transplantation 2003 76: 694 696.
29. Yersiz H Renz JF Farmer DG Hisatake GM McDiarmid SV Busuttil RW. One-hundred in situ split-liver transplantations: a single-center experience. Ann Surg 2003 238: 496 505.
30. Ito T Kiuchi T Egawa H et al. Surgery-related morbidity in living donors of right-lobe liver graft: lessons from the first 200 cases. Transplantation 2003 76: 158 163.
31. Akabayashi A Slingsby BT Fujita M. The first donor death after living-related liver transplantation in Japan. Transplantation 2004 77: 634.
32. Plochl W Spiss CK Plochl E. Death after transplantation of a liver from a donor with unrecognized ornithine transcarbamylase deficiency. N Engl J Med 1999 341: 921 922.